Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in PGEN — Precigen, Inc.

CIK 1387508 NEW YORK, NY

Position in PGEN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,915,105
+$2,198,214 QoQ
Shares Held
1,270,053
+95.4% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Derivatives in PGEN

reported options exposure · as of Sep 30, 2020
CallValue
$2,450
CallShares
700
PutValue
$350
PutShares
100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $75,046,663 across 96 Biotechnology names. PGEN ranks #3 (6.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 PGEN
Precigen, Inc.
This page
1,270,053 $4,915,105

All Filings in PGEN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,915,105 1,270,053
2025-12-31 $2,716,891 649,974
2025-09-30 $886,691 269,511
2025-06-30 $186,147 131,090
2023-12-31 $21,966 16,393
2020-09-30 $2,450 700
2020-09-30 $350 100
2020-06-30 $7,485 1,500
2020-06-30 $499 100